The London-based SPAC said it remains focused on European medium-sized companies in sectors including Industrial Manufacturing, Healthcare & Services, Consumer and Technology. Read more.
Investindustrial Files 3rd Amendment to $350M IPO Registration
Related Posts
Phoenix Biotech Acquisition Looks to Put 3 More Months on the Clock
The SPAC in December mutually terminated a $136 million deal with Intrinsic Medicine.
Accretion Acquisition Files for $150M IPO
Accretion intends to acquire a business involved in the energy value chain, including upstream, water management, gas and vapor capture, energy transition related systems, midstream, oil and gas-related software, commodity risk management or oil and gas services.
Trailblazer Merger I Trims 11% Off Deal Offer Ahead of $60M IPO
The SPAC’s focus remains on US companies within the tech industry.
Bellevue Life Sciences Acquisition Files Proxy on 6-Month Extension to Work on OSR Deal
The deal with the healthcare holding company was announced in November. Peter Kuk Hyoun Hwang is CEO of both companies.